Alteplase for central catheter clearance: 1 mg/mL versus 2 mg/2 mL

Abstract

Get full access to this article

View all access options for this article.

References

1. Haire

Herbst

SE.

The use of alteplase (t-PA) for the management of thrombotic catheter dysfunction. Guidelines from a Consensus Conference of the National Association of Vascular Access Networks. Nutrition Clin Pract 2000;15:265–75.

2. Haire

Atkinson

Stephens

Urokinase versus recombinant tissue plasminogen activator in thrombosed central venous catheters: a double-blinded, randomized trial. Thromb Haemost 1994;72:543–7.

3. Deitcher

Fesen

Kiproff

Hill

McCluskey

Safety and efficacy of alteplase for restoring function in occluded central venous catheters: results of the cardiovascular thrombolytic to open occluded lines trial. J Clin Oncol 2002;20:317–324.

4. Paulsen

Reisaether

Aasen

Fauchald

Use of tissue plasminogen activator for reopening of clotted dialysis catheters. Nephron 1993;64:468–70.

5. Blackwelder

“Proving the null hypothesis” in clinical trials. Controlled Clin Trials 1982;3:345–53.